Christopher D Alafi Intra Cellular Therapies, Inc. (ITCI) insider trading activity

ITCI Quotes by TradingView

Christopher D Alafi is Director of Intra-Cellular Therapies, Inc.. Currently has a direct ownership of 346,795 shares of ITCI, which is worth approximately $26.2 Million. The most recent transaction as insider was on Mar 31, 2021, when has been sold 464 shares (Common Stock) at a price of $33.93 per share, resulting in proceeds of $15,744. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 347K
0% 3M change
0% 12M change
Total Value Held $26.2 Million

Christopher D Alafi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2021
BUY
Grant, award, or other acquisition
$15,744 $33.93 p/Share
464 Added 0.13%
346,795 Common Stock
Dec 31 2020
BUY
Grant, award, or other acquisition
$15,741 $31.8 p/Share
495 Added 0.14%
346,331 Common Stock
Sep 30 2020
BUY
Grant, award, or other acquisition
$15,730 $25.66 p/Share
613 Added 0.18%
345,836 Common Stock
CDA

Christopher D Alafi

Director
Emeryville, CA

Track Institutional and Insider Activities on ITCI

Follow Intra-Cellular Therapies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITCI shares.

Notify only if

Insider Trading

Get notified when an Intra Cellular Therapies, Inc. insider buys or sells ITCI shares.

Notify only if

News

Receive news related to Intra-Cellular Therapies, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ITCI